Revealing the indispensable role of the RFamide functionality using a novel acid labile benzofuranone based amine (ALBA) linker

Show simple item record

dc.contributor.author Mudd, Gemma
dc.contributor.author Hendrikse, Megan
dc.contributor.author Shave, Steven
dc.contributor.author Houston, Douglas R.
dc.contributor.author Millar, Robert P.
dc.contributor.author Auer, Manfred
dc.date.accessioned 2024-06-25T06:26:43Z
dc.date.available 2024-06-25T06:26:43Z
dc.date.issued 2024-04
dc.description DATA AVAILABILITY STATEMENT : The data that support the findings of this study are available from the corresponding author upon reasonable request. en_US
dc.description This article also appears in: Andrea Vasella 80th Birthday Biochemistry and Medicinal Chemistry Organic and Organometallic Chemistry. en_US
dc.description.abstract The RFamide family of peptides represents an important class of GPCR ligand neuropeptides covering a wide range of biological functions. While many analogues of the highly conserved C-terminal RFamide motif within this peptide class have been synthesized and their functional significance elucidated, additional exploration of the structure activity relationship is of value. We have developed a novel linker for solid phase peptide synthesis (SPPS) which is able to anchor amine functionalised compounds for further elaboration. The acid labile benzofuranone based amine (ALBA) linker (5-(3-aminopropylcarbamoyl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]benzoic acid) is compatible with Fmoc based SPPS and has two cleavage modes. As a proof of concept, the ALBA linker was used to successfully synthesise a novel analogue of Kisspeptin 10, the natural ligand for GPCR54, whereby the natural RFamide motif was replaced with an RFamine. Biological evaluation of the amine-containing analogue revealed that the group is not compatible with receptor activation. en_US
dc.description.department Immunology en_US
dc.description.librarian hj2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.sponsorship This work was completed as part of a BioSKAPE studentship funded by SULSA, the BBSRC and Pfizer Ltd. Support is also acknowledged from the Scottish Universities Life Sciences Alliance (SULSA) and the Medical Research Council (MRC9) Strategic Grant. en_US
dc.description.uri https://onlinelibrary.wiley.com/journal/15222675 en_US
dc.identifier.citation Mudd, G., Hendrikse, M., Shave, S. et al. 2024, 'Revealing the indispensable role of the RFamide functionality using a novel acid labile benzofuranone based amine (ALBA) linker', Helvetica Chimica Acta, vol. 107, no. 4, art. e202300204, pp. 1-7, doi : 10.1002/hlca.202300204. en_US
dc.identifier.issn 0018-019X (print)
dc.identifier.issn 1522-2675 (online)
dc.identifier.other 10.1002/hlca.202300204
dc.identifier.uri http://hdl.handle.net/2263/96632
dc.language.iso en en_US
dc.publisher Wiley en_US
dc.rights © 2024 The Authors. Helvetica Chimica Acta published by Wiley-VHCA AG. en_US
dc.subject Cleavable linker en_US
dc.subject Kisspeptin en_US
dc.subject GPR54 en_US
dc.subject G-protein coupled receptor (GPCR) en_US
dc.subject RFamide en_US
dc.subject Solid phase peptide synthesis (SPPS) en_US
dc.subject Acid labile benzofuranone based amine (ALBA) en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title Revealing the indispensable role of the RFamide functionality using a novel acid labile benzofuranone based amine (ALBA) linker en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record